BMEYE Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$36.8M
BMEYE General Information
Description
Developer and manufacturer of cardiovascular monitoring devices. The company offers products and technologies to measure blood pressure and cardiac output. It has two products approved for sale in the U.S. and Europe from the platform Nexfin, for the cardiology market, and ccNexfin, for the anesthesia and critical care markets.
Contact Information
Website
www.bmeye.comCorporate Office
- Centerpoint 1, 4th floor
- Hoogoorddreef 60
- 1101 Amsterdam
- Netherlands
Corporate Office
- Centerpoint 1, 4th floor
- Hoogoorddreef 60
- 1101 Amsterdam
- Netherlands
BMEYE Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 09-Oct-2012 | $36.8M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series B) | 08-Oct-2009 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 01-Jan-2006 | $3.56M | $3.56M | Completed | Product Development |
BMEYE Patents
BMEYE Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2502555-A1 | Non-invasive oxygen delivery measurement system and method | Inactive | 22-Mar-2011 | ||
| EP-2713859-A1 | Non-invasive oxygen delivery measurement system and method | Inactive | 22-Mar-2011 | ||
| US-20150080669-A1 | Non-invasive oxygen delivery measurement system and method | Inactive | 22-Mar-2011 | ||
| WO-2012126798-A1 | Non-invasive oxygen delivery measurement system and method | Inactive | 22-Mar-2011 | ||
| US-10383724-B2 | Cardiac valve repair system and methods of use | Active | 19-Jul-2010 | A61F2/2409 |
BMEYE Signals
BMEYE Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 360 Capital | Venture Capital | Minority | ||
| Business Angels Technostarters | Venture Capital | Minority | ||
| EQT Life Sciences | Venture Capital | Minority | ||
| Earlybird Venture Capital | Venture Capital | Minority | ||
| Gefen Biomed Investments | Venture Capital | Minority |
BMEYE FAQs
-
When was BMEYE founded?
BMEYE was founded in 2005.
-
Where is BMEYE headquartered?
BMEYE is headquartered in Amsterdam, Netherlands.
-
What is the size of BMEYE?
BMEYE has 10 total employees.
-
What industry is BMEYE in?
BMEYE’s primary industry is Monitoring Equipment.
-
Is BMEYE a private or public company?
BMEYE is a Private company.
-
What is the current valuation of BMEYE?
The current valuation of BMEYE is .
-
What is BMEYE’s current revenue?
The current revenue for BMEYE is .
-
How much funding has BMEYE raised over time?
BMEYE has raised $12.4M.
-
Who are BMEYE’s investors?
360 Capital, Business Angels Technostarters, EQT Life Sciences, Earlybird Venture Capital, and Gefen Biomed Investments are 5 of 6 investors who have invested in BMEYE.
-
When was BMEYE acquired?
BMEYE was acquired on 09-Oct-2012.
-
Who acquired BMEYE?
BMEYE was acquired by Edwards Lifesciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process